|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 45/06 | (2006.01) |
| A61K 31/426 | (2006.01) | ||
| A61P 31/12 | (2006.01) |
| (11) | Number of the document | 3436074 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17716741.8 |
| Date of filing the European patent application | 2017-03-30 | |
| (97) | Date of publication of the European application | 2019-02-06 |
| (45) | Date of publication and mention of the grant of the patent | 2020-06-10 |
| (46) | Date of publication of the claims translation | 2020-09-25 |
| (86) | Number | PCT/US2017/024976 |
| Date | 2017-03-30 |
| (87) | Number | WO 2017/173056 |
| Date | 2017-10-05 |
| (30) | Number | Date | Country code |
| 201662316463 P | 2016-03-31 | US |
| (72) |
ROSSIGNOL, Jean-Francois, US
SANTORO, Maria Gabriella, US
|
| (73) |
Romark Laboratories, L.C.,
3000 Bayport Drive Suite 200, Tampa, FL 33607,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Tiazolido junginiai, skirti virusinių infekcijų gydymui |
| THIAZOLIDE COMPOUNDS FOR TREATING VIRAL INFECTIONS |
| Payment date | Validity (years) | Amount | |
| 2023-09-26 | 7 | 243.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-03-30 |